Back to today’s briefing

Story perspectives

Trump's Drug Deal Sparks Debate Over Effectiveness

10/20/2025

23 4 Full Breakdown

Summary

Story summary

The Big Beautiful Bill, signed by Donald J. Trump (former President) in August, expands Medicare price-negotiation exemptions for more drugs.
A deal with Pfizer will allow Medicaid purchases at international prices and offer consumer discounts via Trumprx.gov, slated to launch in 2026.
Experts question the initiative's effectiveness, noting that only 10% of consumers buy drugs directly and that private firms already offer similar discounts.

History

Historical Context

The Medicare Prescription Drug, Improvement, and Modernization Act, signed by President George W. Bush on December 8, 2003, marked a significant overhaul of Medicare, introducing prescription drug coverage for seniors and allocating $400 billion over ten years. This legislation prohibited Medicare from negotiating drug prices, a restriction recently challenged by the Inflation Reduction Act, aiming to improve drug affordability for consumers.

1 of 2

Story summary

The Big Beautiful Bill, signed by Donald J. Trump (former President) in August, expands Medicare price-negotiation exemptions for more drugs.
A deal with Pfizer will allow Medicaid purchases at international prices and offer consumer discounts via Trumprx.gov, slated to launch in 2026.
Experts question the initiative's effectiveness, noting that only 10% of consumers buy drugs directly and that private firms already offer similar discounts.

1 / 2